iRhythm Technologies, Inc.·4

Jan 28, 6:50 PM ET

Vort David A 4

4 · iRhythm Technologies, Inc. · Filed Jan 28, 2021

Insider Transaction Report

Form 4
Period: 2021-01-26
Vort David A
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2021-01-26$63.95/sh+5,000$319,75027,126 total
  • Sale

    Common Stock

    [F1][F2]
    2021-01-26$243.84/sh500$121,92026,626 total
  • Sale

    Common Stock

    [F1]
    2021-01-26$244.70/sh271$66,31426,355 total
  • Sale

    Common Stock

    [F1][F3]
    2021-01-26$246.57/sh1,165$287,25025,190 total
  • Sale

    Common Stock

    [F1][F4]
    2021-01-26$248.17/sh1,288$319,64623,902 total
  • Sale

    Common Stock

    [F1][F5]
    2021-01-26$249.28/sh1,276$318,08222,626 total
  • Sale

    Common Stock

    [F1][F6]
    2021-01-26$250.57/sh500$125,28622,126 total
  • Exercise/Conversion

    Common Stock

    [F1][F7]
    2021-01-265,0007,218 total
    Exercise: $63.95From: 2019-03-01Exp: 2028-02-27Common Stock (5,000 underlying)
Footnotes (7)
  • [F1]The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2020.
  • [F2]This transaction was executed in multiple trades at prices ranging from $243.52 to $244.29 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F3]This transaction was executed in multiple trades at prices ranging from $246.05 to $246.99 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F4]This transaction was executed in multiple trades at prices ranging from $247.955 to $248.77 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F5]This transaction was executed in multiple trades at prices ranging from $249.01 to $249.97 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F6]This transaction was executed in multiple trades at prices ranging from $250.45 to $251.06 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F7]This option, originally granted for 15,100 shares, of which 7,882 shares have been exercised, vested as to 1/4 of the shares on March 1, 2019 and as to 1/36 of the remaining shares each month thereafter.
Signature
/s/ Christina Delfin, attorney in fact|2021-01-28

Documents

1 file
  • 4
    wf-form4_161187781879736.xmlPrimary

    FORM 4